Table 3 Levels of selected candidates in Verification phase.
Proteins | Cad (n = 20) | Control (n = 20) | Ratio | p value |
|---|---|---|---|---|
Alpha-1-acid glycoprotein 2 (g/L) | 0.7 (0.5–0.89) | 0.61 (0.57–0.8) | 1.14 | 0.796 |
Apolipoprotein A-I (mg/dL) | 97.39 (70.5–107.2) | 115.49 (104.51–141.38) | 0.8432 | 0.001 |
Apolipoprotein B (mg/dL) | 51.56 (40.57–64.11) | 87.25 (79.12–100.88) | 0.59 | <0.0001 |
Albumin (g/dL) | 3.95 (3.62–4.27) | 4.3 (4.12–4.5) | 0.918 | 0.001 |
Alpha-1-antitrypsin (g/L) | 1.21 (1.07–1.36) | 1.2 (1.13–1.32) | 1.008 | 0.547 |
Haptoglobin (g/L) | 1.09 (0.79–1.55) | 1.0 (0.6–1.35) | 1.09 | 0.529 |
Apolipoprotein A-IV (ug/ml) | 5.96 (3.69–13.17) | 12.7 (9.49–18.59) | 0.469 | 0.0045 |
Adiponectin (ng/ml) | 6087.7 (4143.1–8469.46) | 8690 (6887–11578) | 0.7005 | 0.0025 |
Serum amyloid P-component (ng/ml) | 37595 (21581–71477.8) | 66672.7 (44503.3–100244.0) | 0.563 | 0.028 |
Glutathione peroxidase 3 (μg/ml) | 3.02 (1.71–3.93) | 3.65 (2.87–4.86) | 0.82 | 0.0338 |
Peroxiredoxin-2(ng/ml) | 136.6 (125.2–159.5) | 154.91(150.44–185.26) | 0.881 | 0.0106 |
Apolipoprotein C-I (μg/ml) | 112.95 (101.55–128.79) | 124.71(113.2–138.62) | 0.905 | 0.16 |
Actin cytoplasmic-2 (μg/ml) | 3.59 (3.36–3.87) | 3.91 (3.61–4.24) | 0.918 | 0.056 |
Fibrinogen Gamma Chain (μg/ml) | 5299.5 (968.6–9818.1) | 5448.4 (291.3–9818.1) | 0.972 | 0.88 |
Transferrin (mg/dL) | 520.01 (119.6–1253.9) | 515.25 (145.72–1310.2) | 1.009 | 0.59 |
Vitronectin (μg/ml) | 48.44 (14.40–99.06) | 58.98 (8.84–103.02) | 0.8212 | 0.88 |
Thymosin beta-4 (ng/ml) | 4.48 (3.58–5.95) | 4.44 (3.33–6.19) | 1.009 | 0.685 |
Dermicidine(ng/ml) | 28.27 (21–33.36) | 23.67 (20.45–29.24) | 1.19 | 0.137 |
ApoC2(μg/ml) | 124.05 (91.71–229.99) | 75.28 (49.28–106.48) | 1.64 | 0.002 |
AMBP(mg/ml) | 20.90 (17.30–25.23) | 22.22 (16.02–27.57) | 0.94 | 0.808 |
PZP (μg/ml) | 34.43 (15.64–50.74) | 55.96 (36.97–75.45) | 0.615 | 0.010 |
Apol1 (μg/ml) | 60.19 (47.47–90.41) | 59.89 (22.85–73.04) | 1.005 | 0.176 |
